This is of potential clinical relevance, as further defining the commonalities and differences between GLP-1R agonists and bariatric surgery in terms of their central mechanism of action may not only help bridge the gap between the pharmacological and surgical treatments for obesity but may also provide a neural basis for their combined use when each individually fail [174, 175]
GIP (Glucose-Dependent Insulinotropic Polypeptide) Improves insulin sensitivity and appears to promote more favorable fat distribution (less visceral fat around organs, more subcutaneous fat under the skin)
Individual results vary based on medical history, starting weight, adherence to treatment, lifestyle factors, and provider recommendations
Ankle oedema and sympathetic activation
At Metabolic Medical Center in Mount Pleasant, Charleston, Murrells Inlet, Columbia, and Bluffton, South Carolina, Meridith Womick, MD, and the team are dedicated to providing their patients with all the tools they need to reach their healthy weight
Your healthcare provider will likely suggest gradually reducing the dose
